BSECompany Update5d ago · 14 Aug 2026, 05:59 pm

Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 162A of SEBI (Issue of ....

Kilburn Engineering Ltd · 522101

✦ AI SummaryFundraise

Kilburn Engineering Ltd has submitted a Monitoring Agency Report for the first quarter ended June 30, 2026, as per SEBI regulations, detailing the utilization of proceeds from a preferential issue of Rs. 290.65 crore.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Kilburn Engineering Ltd - 522101 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Attachments (1)

📄

2a18cf80-c667-4b1f-ab4f-5968ad4fb3fc.pdf

pdf

Download →
View document text
Date : 14th August, 2026 The Corporate Relationship Department BSE Limited P.J. Tower Dalal Street, Fort Mumbai - 400 001 Scrip Code: BSE 522101 Sub: Monitoring Agency Report for the first quarter ended 30th June, 2026 Pur suant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 162A of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, enclosed herewith the Monitoring Agency Report for the first quarter ended 30th June, 2026, issued by Care Ratings Limited, Monitoring Agency, appointed to monitor the utilisation of proceeds of the funds raised through preferential issue. We request you to take the same on your record. For Kilburn Engineering Limited Abhijit Mehta Company Secretary & Compliance Officer Encl :A/a No. CARE/KRO/GEN/2026-27/1071 The Board of Directors Kilburn Engineering Limited Plot No-6, Kalyan Bhiwandi Road Saravali, Thane Maharashtra, 421311 August 14, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Preferential Issue of Kilburn Engineering Limited (“the Company”) We write in our capacity of Monitoring Agency for the Preferential Issue for the amount aggregating to Rs. 290.65 crore (revised from Rs. 299.63 crore) of the Company and refer to our duties cast under Regulation 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated August 27, 2024. Request you to kindly take the same on records. Thanking you, Yours faithfully, Kamal Mahipal Associate Director Kamal.Mahipal@careedge.in CARE Ratings Limited Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital 15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East), Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in CIN-L67190MH1993PLC071691 Report of the Monitoring Agency Name of the issuer: Kilburn Engineering Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Not Applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Kamal Mahipal Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital 15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East), Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in CIN-L67190MH1993PLC071691 1) Issuer Details: Name of the issuer : Kilburn Engineering Limited Name of the promoter : Firstview Trading Private Limited, Williamson Magor & Co. Limited and Khaitan Family. Industry/sector to which it belongs : Manufacturing 2) Issue Details Issue Period : November 16, 2024, and November 19, 2024 Type of issue (public/rights) : Preferential Issue Type of specified securities : Equity shares and Convertible warrants IPO Grading, if any : Not Applicable Issue size (in crore) : Rs.290.65 crore (revised from Rs. 299.63 crore) 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Monitoring Agency Board of Directors preparation of report Due to forfeiture of 235,000 Due to forfeiture of 235,000 convertible warrants on account of convertible warrants on account of non-payment of balance 75% of the non-payment of balance 75% of the warrant subscription (due date of May warrant subscription (due date of May 15, 2026) and non-subscription of 15, 2026) and non-subscription of 35,000 equity shares under preferential 35,000 equity shares under preferential issue, the total issue size has been issue, the total issue size has been AGM resolution dated September 20, revised from Rs.299.63 crore to revised from Rs.299.63 crore to Whether all utilization is as per the disclosures in the 2024, Board Resolution dated May 26, Rs.290.65 crore as per Board Rs.290.65 crore as per Board Offer Document? 2026, Management certificate, Statutory Resolution dated May 26, 2026. Resolution dated May 26, 2026. Auditor’s certificate*. Accordingly, the allocation amount Accordingly, the allocation amount towards General Corporate Purposes towards General Corporate Purposes has been revised from Rs 74.00 crore to has been revised from Rs 74.00 crore to Rs 65.02 crore. Rs 65.02 crore. As per the revised cost of objects Board As per the revised cost of objects Resolution dated May 26, 2026, the Board Resolution dated May 26, 2026, utilization of funds is as per revised the utilization of funds is as per revised objects. objects. Whether shareholder approval has been obtained in Not Applicable Management certificate Not Applicable NA CARE Ratings Limited Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital 15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East), Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in CIN-L67190MH1993PLC071691 Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Monitoring Agency Board of Directors preparation of report case of material deviations# from expenditures disclosed in the Offer Document? As explained above, the means of As explained above, the means of finance for the disclosed objects of the finance for the disclosed objects of the issue have been changed due to the issue have been changed due to the AGM resolution dated Septem [Showing first 8,000 characters — download PDF for full document]